Neoadjuvant endocrine therapy underused for breast cancer
Roughly five years ago, a study demonstrated that neoadjuvant endocrine therapy increases the rates of breast conservation surgery in patients with breast cancer as a result of the downstaging of disease. Now, an analysis of roughly 80,000 women with breast cancer in the United States shows that this study has done little to increase the use of this treatment modality.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063